Coverage of several self-administered DMARDs declined across Medicare Part D plans between 2022 and 2026, with differential coverage noted across plan types.

Telemedicine adoption was not associated with changes in visit numbers or medical spending among insured adults.

Reference fabrication has increased among published medical research papers, with the rate of fabrication growing from 2025 to 2026.

A targeted birth-dose vaccine recommendation for hepatitis B virus in the United States would likely increase neonatal infections.

Aluminum-adjuvanted vaccines showed no association with long-term health outcomes, including asthma and autism spectrum disorder.